Celsion names chief medical officer

Sep 26, 2007

Medical R&D firm Celsion of Columbia, MD, announced that it has appointed Dr. Nicholas Borys to the position of vice president and chief medical officer (CMO).

Borys, who will manage Celsion's clinical development program, most recently served as CMO at Molecular Insight Pharmaceuticals. He has also held senior positions as Taiho Pharma USA, Cytogen, Anthra Pharmaceuticals, Amersham Healthcare, and Hoffmann-La Roche.

By AuntMinnie.com staff writers
September 27, 2007

Related Reading

Celsion sells subsidiary to former CEO, January 17, 2006

Celsion receives CPT code, July 24, 2003

Celsion applies for phase II trials of breast cancer ablation system, November 10, 2002

Copyright © 2007 AuntMinnie.com

Latest in Clinical News
Liver Cancer
Dual-tracer PET/CT shows promise in liver cancer patients
April 26, 2024
Transgender Pride Symbol Social
Studies lacking for trans breast cancer screening trends
April 25, 2024
Register today for a FREE webinar May 8 at 12 Noon EDT
Sponsored
Register today for a FREE webinar May 8 at 12 Noon EDT
April 24, 2024
3 D Lungs Covid Virus Cells
CT reveals influence of diabetes on COVID-19 severity
April 25, 2024
Related Stories
2007 09 24 14 55 04 706
MRI
Does MRI help in treatment of second breast cancers? Don't be too sure
2007 09 21 11 15 29 706
CT
Premium CT market proliferates with new purchasing options
2007 09 19 14 41 15 706
CT
Slice thickness, reading method don't change VC results
My BreastAI Suite by GE HealthCare
Sponsor Content
My BreastAI Suite by GE HealthCare
More in Clinical News
Dual-tracer PET/CT shows promise in liver cancer patients
By Will Morton
Dual-tracer PET/CT appears valuable for improving tumor staging in patients with hepatocellular carcinoma being evaluated for treatment.
April 26, 2024
Liver Cancer
Studies lacking for trans breast cancer screening trends
By Amerigo Allegretto
There are limited studies examining breast cancer screening trends in transgender people.
April 25, 2024
Transgender Pride Symbol Social
ChatGPT-4 not reliable in cancer patient messaging
By Amerigo Allegretto
ChatGPT-4 is not a reliable source for answering patients’ questions regarding cancer and needs physician monitoring.
April 25, 2024
Chat Gpt Artificial Intelligence Ai Head
CT reveals influence of diabetes on COVID-19 severity
By Kate Madden Yee
CT imaging reveals the influence of blood glucose levels on the severity of COVID-19, researchers have reported.
April 25, 2024
3 D Lungs Covid Virus Cells
Clinical practice LCS program finds more disease than NLST
By Kate Madden Yee
A clinical practice lung cancer screening (LCS) program at Duke University Medical Center found more disease than did the National Lung Screening Trial (NLST).
April 24, 2024
Lung Illustration Blue
SPECT/CT predicts foot amputations in diabetics
By Will Morton
Technetium-99m white blood cell SPECT/CT imaging may be useful for identifying diabetic patients at risk of amputations due to foot infections.
April 24, 2024
Examples in two patients. (Top) Abnormal leukocyte accumulation was observed in the right 1st to 5th toes, with the radioactive lesions extending to the bone, indicating osteomyelitis (left panel, MIP image; right panel, axial SPECT/CT). Two spherical VOIs were drawn on diabetic foot infections (DFIs) and the highest SUVmax was 4.2 (higher than the cutoff of 1.1) Despite intensive treatment, the infection progressed, leading to the patient undergoing right below knee amputation 43 days after SPECT/CT. (Bottom) Mild focal abnormal leukocyte accumulation was detected in the right 3rd and 4th toes. The lesions were in contact with the bone, which raised a suspicion of osteomyelitis (left panel, MIP image; right panel, axial SPECT/CT). A circular VOI was drawn on DFIs and the SUVmax was 1.0 (lower than the cutoff of 1.1). After 10 weeks of antibiotic treatment, the infection was successfully resolved, and the foot was preserved. Image and caption courtesy of Scientific Reports.
Deep-learning algorithm improves liver fibrosis diagnosis
By Amerigo Allegretto
An algorithm combining the Fibrosis-4 Index and an ultrasound deep-learning model could improve diagnostic accuracy for advanced liver fibrosis.
April 23, 2024
Ultrasound Scanner Ultraviolet 400
Novel risk prediction model improves LCS uptake
By Kate Madden Yee
A novel risk prediction model used in the Ontario Lung Cancer Screening Pilot increased the uptake of lung cancer screening among eligible Canadians, researchers have found.
April 23, 2024
Lung Cancer
PET/CT superior to MRI for detecting spinal bone metastases
By Will Morton
Gallium-68 (Ga-68) DOTATATE PET/CT appears to be the best approach for detecting spinal bone metastases in patients with certain neuroendocrine tumors.
April 23, 2024
Ppgl 167 250
NLP uncovers racial bias in documenting ob/gyn imaging findings
By Amerigo Allegretto
Natural language processing (NLP), a form of AI, can uncover racial bias in documenting radiology-confirmed ob/gyn findings.
April 23, 2024
Chat Gpt Artificial Intelligence Ai Head
Neuroimaging detects blast exposure brain injuries in U.S. soldiers
By Will Morton
A battery of MRI and PET neuroimaging tests show patterns of brain injury in active-duty U.S. soldiers caused by repeated blast exposures.
April 22, 2024
Military
MR elastography effective for assessing liver stiffness in children
By Kate Madden Yee
MR elastography is an effective technique for noninvasive monitoring of liver stiffness -- a surrogate for fibrosis -- in children and young adults with autoimmune liver disease, researchers have reported.
April 19, 2024
2024 04 19 7 Year Old Boy With Autoimmune Sclerosing Cholangitis
Page 1 of 3588
Next Page